These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23997223

  • 1. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM, Esmon NL, Esmon CT, Bynoe MS.
    J Immunol; 2013 Oct 01; 191(7):3764-77. PubMed ID: 23997223
    [Abstract] [Full Text] [Related]

  • 2. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
    Wu F, Dang D, Guo J, Li H, Yang K, Zhao D, Guo P, Li Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug 01; 30(8):789-92, 797. PubMed ID: 25108427
    [Abstract] [Full Text] [Related]

  • 3. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.
    Chung JS, Tamura K, Akiyoshi H, Cruz PD, Ariizumi K.
    J Immunol; 2014 Mar 15; 192(6):2576-84. PubMed ID: 24516197
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells.
    Arellano G, Acuña E, Loda E, Moore L, Tichauer JE, Castillo C, Vergara F, Burgos PI, Penaloza-MacMaster P, Miller SD, Naves R.
    J Neuroinflammation; 2024 May 31; 21(1):144. PubMed ID: 38822334
    [Abstract] [Full Text] [Related]

  • 5. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV, Wu L, Olivares-Villagómez D, Wilson KT, Van Kaer L.
    J Immunol; 2013 Mar 01; 190(5):1948-60. PubMed ID: 23345328
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
    Drohomyrecky PC, Doroshenko ER, Akkermann R, Moshkova M, Yi TJ, Zhao FL, Ahn JJ, McGaha TL, Pahan K, Dunn SE.
    J Immunol; 2019 Nov 15; 203(10):2588-2601. PubMed ID: 31578267
    [Abstract] [Full Text] [Related]

  • 7. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S, Périnat T, Greene G, Enzmann G, Deutsch U, Adams R, Imhof B, Aurrand-Lions M, Engelhardt B.
    Brain Behav Immun; 2018 Oct 15; 73():3-20. PubMed ID: 29920328
    [Abstract] [Full Text] [Related]

  • 8. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H, Guo C, Yu X, Zuo D, Wang XY.
    J Immunol; 2012 Nov 01; 189(9):4295-304. PubMed ID: 23034169
    [Abstract] [Full Text] [Related]

  • 9. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
    Wegner A, Verhagen J, Wraith DC.
    Immunology; 2017 May 01; 151(1):26-42. PubMed ID: 28140447
    [Abstract] [Full Text] [Related]

  • 10. Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE.
    Mindur JE, Ito N, Dhib-Jalbut S, Ito K.
    PLoS One; 2014 May 01; 9(6):e99068. PubMed ID: 24896098
    [Abstract] [Full Text] [Related]

  • 11. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.
    Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ.
    J Immunol; 2007 Oct 15; 179(8):5228-37. PubMed ID: 17911608
    [Abstract] [Full Text] [Related]

  • 12. NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells.
    Wang JL, Li B, Tan GJ, Gai XL, Xing JN, Wang JQ, Quan MY, Zhang N, Guo L.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32301489
    [Abstract] [Full Text] [Related]

  • 13. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA, Waldner H, Zagon IS, McLaughlin PJ.
    Exp Biol Med (Maywood); 2016 Jan 30; 241(1):71-8. PubMed ID: 26202376
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS.
    Front Immunol; 2018 Jan 30; 9():1782. PubMed ID: 30123217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels.
    He Y, Du M, Gao Y, Liu H, Wang H, Wu X, Wang Z.
    PLoS One; 2013 Jan 30; 8(10):e76495. PubMed ID: 24124567
    [Abstract] [Full Text] [Related]

  • 19. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
    Lee MJ, Bing SJ, Choi J, Jang M, Lee G, Lee H, Chang BS, Jee Y, Lee SJ, Cho IH.
    Mol Neurodegener; 2016 Jul 22; 11(1):54. PubMed ID: 27450563
    [Abstract] [Full Text] [Related]

  • 20. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S, Toyka K, Hartung HP.
    Eur J Immunol; 1995 May 22; 25(5):1391-8. PubMed ID: 7539758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.